Trial · NCT00165776
Results by group28
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 28
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Mean Change From Baseline in Patient Global Assessment - Visual Analog Scale (PtGA-VAS) at Week 4 After Treatment | Placebo | -0.4 | Standard Error 3.2 | Millimeters | |
| Mean Change From Baseline in Patient Global Assessment - Visual Analog Scale (PtGA-VAS) at Week 4 After Treatment | E2014 2,500 U | 11.9 | Standard Error 2.6 | Millimeters | |
| Mean Change From Baseline in Patient Global Assessment - Visual Analog Scale (PtGA-VAS) at Week 4 After Treatment | E2014 5,000 U | 9.9 | Standard Error 3 | Millimeters | |
| Mean Change From Baseline in Patient Global Assessment - Visual Analog Scale (PtGA-VAS) at Week 4 After Treatment | E2014 10,000 U | 13.3 | Standard Error 3 | Millimeters | |
| Mean Change From Baseline in Physician Global Assessment Disease Assessment - Visual Analog Scale (PGA-VAS) at Week 4 After Treatment | Placebo | 2 | Standard Error 2.2 | Millimeters | |
| Mean Change From Baseline in Physician Global Assessment Disease Assessment - Visual Analog Scale (PGA-VAS) at Week 4 After Treatment | E2014 2,500 U | 10.6 | Standard Error 2.9 | Millimeters | |
| Mean Change From Baseline in Physician Global Assessment Disease Assessment - Visual Analog Scale (PGA-VAS) at Week 4 After Treatment | E2014 5,000 U | 11.2 | Standard Error 2.6 | Millimeters | |
| Mean Change From Baseline in Physician Global Assessment Disease Assessment - Visual Analog Scale (PGA-VAS) at Week 4 After Treatment | E2014 10,000 U | 16.9 | Standard Error 2.8 | Millimeters | |
| Mean Change From Baseline in the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) -Total Score at Week 4 After Treatment | Placebo | 3 | Standard Error 1.3 | Points on a Scale | |
| Mean Change From Baseline in the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) -Total Score at Week 4 After Treatment | E2014 2,500 U | 8.9 | Standard Error 1.8 | Points on a Scale | |
| Mean Change From Baseline in the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) -Total Score at Week 4 After Treatment | E2014 5,000 U | 7.6 | Standard Error 1.6 | Points on a Scale | |
| Mean Change From Baseline in the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) -Total Score at Week 4 After Treatment | E2014 10,000 U | 10.5 | Standard Error 1.6 | Points on a Scale | |
| Mean Change From Baseline in the TWSTRS - Functional Disability Score at Week 4 After Treatment | Placebo | 0.6 | Standard Error 0.7 | Points on a Scale | |
| Mean Change From Baseline in the TWSTRS - Functional Disability Score at Week 4 After Treatment | E2014 2,500 U | 2.5 | Standard Error 0.6 | Points on a Scale | |
| Mean Change From Baseline in the TWSTRS - Functional Disability Score at Week 4 After Treatment | E2014 5,000 U | 1.9 | Standard Error 0.8 | Points on a Scale | |
| Mean Change From Baseline in the TWSTRS - Functional Disability Score at Week 4 After Treatment | E2014 10,000 U | 3.1 | Standard Error 0.5 | Points on a Scale | |
| Mean Change From Baseline in the TWSTRS - Pain Score at Week 4 After Treatment | Placebo | 0.8 | Standard Error 0.4 | Points on a Scale | |
| Mean Change From Baseline in the TWSTRS - Pain Score at Week 4 After Treatment | E2014 2,500 U | 2.9 | Standard Error 0.7 | Points on a Scale | |
| Mean Change From Baseline in the TWSTRS - Pain Score at Week 4 After Treatment | E2014 5,000 U | 2 | Standard Error 0.7 | Points on a Scale | |
| Mean Change From Baseline in the TWSTRS - Pain Score at Week 4 After Treatment | E2014 10,000 U | 2.7 | Standard Error 0.7 | Points on a Scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00165776/results